Heron Therapeutics (HRTX) Set to Announce Earnings on Tuesday

Heron Therapeutics (NASDAQ:HRTX) is scheduled to be posting its quarterly earnings results before the market opens on Tuesday, November 12th. Analysts expect Heron Therapeutics to post earnings of ($0.03) per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

Heron Therapeutics (NASDAQ:HRTX) last issued its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.02). The firm had revenue of $36.02 million for the quarter, compared to analysts’ expectations of $35.35 million. During the same period in the prior year, the company earned ($0.35) EPS.

Heron Therapeutics Stock Down 3.9 %

NASDAQ:HRTX traded down $0.07 during trading hours on Tuesday, hitting $1.71. 346,938 shares of the company traded hands, compared to its average volume of 2,396,292. Heron Therapeutics has a one year low of $0.50 and a one year high of $3.93. The company has a market cap of $259.36 million, a PE ratio of -5.42 and a beta of 1.81. The firm’s 50-day simple moving average is $1.88 and its 200-day simple moving average is $2.58.

Analysts Set New Price Targets

Separately, Needham & Company LLC reiterated a “buy” rating and issued a $5.00 price objective on shares of Heron Therapeutics in a research note on Wednesday, September 25th.

Heron Therapeutics Company Profile

Heron Therapeutics, Inc, a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.